Folia Parasitologica 67:015 (2020) | DOI: 10.14411/fp.2020.015

Neurological disorder and psychosocial aspects of cerebral malaria: what is new on its pathogenesis and complications? A minireview.

Arif Jamal Siddiqui1#*, Mohd Adnan1#, Sadaf Jahan2, Whitni Redman3, Mοhd Saeed1, Mitesh Patel4
# Both authors have contributed equally and should be considered as first authors,
1 Department of Biology, College of Science, University of Hail, Hail, PO Box 2440, Saudi Arabia;
2 Department of Medical Laboratory, College of Applied Medical Sciences, Majmaah University, Majmaah city, Saudi Arabia;
3 Surgery Department, Division of Biomedical Research, Texas Tech University Health Sciences Center, Lubbock, Texas, USA;
4 Bapalal Vaidya Botanical Research Centre, Department of Biosciences, Veer Narmad South Gujarat University, Surat, Gujarat, India

Recently, malaria is remain considered as the most prevalent infectious disease, affecting the human health globally. High morbidity and mortality worldwide is often allied with cerebral malaria (CM) based disorders of the central nervous system, especially across many tropical and sub-tropical regions. These disorders are characterised by the infection of Plasmodium species, which leads to acute or chronic neurological disorders, even after having active/effective antimalarial drugs. Furthermore, even during the treatment, individual remain sensitive for neurological impairments in the form of decrease blood flow and vascular obstruction in brain including many more other changes. This review briefly explains and update on the epidemiology, burden of disease, pathogenesis and role of CM in neurological disorders with behaviour and function in mouse and human models. Moreover, the social stigma, which plays an important role in neurological disorders and a factor for assessing CM, is also discussed in this review.

Keywords: Antimalarial, Plasmodium, neuropathology, iRBC, cognitive disability

Received: October 11, 2019; Revised: January 20, 2020; Accepted: March 6, 2020; Published online: May 27, 2020  Show citation

ACS AIP APA ASA Harvard Chicago IEEE ISO690 MLA NLM Turabian Vancouver
Siddiqui, A.J., Adnan, M., Jahan, S., Redman, W., Saeed, M., & Patel, M. (2020). Neurological disorder and psychosocial aspects of cerebral malaria: what is new on its pathogenesis and complications? A minireview. Folia Parasitologica67, Article 2020.015. https://doi.org/10.14411/fp.2020.015
Download citation

References

  1. Ahmed M.A., Cox-Singh J. 2015: Plasmodium knowlesi - an emerging pathogen. ISBT Sci. Ser. 10: 134-140. Go to original source... Go to PubMed...
  2. Alavi Y., Jumbe V., Hartley S., Smith S., Lamping D., Muhit M., Masiye F., Lavy C. 2012: Indignity, exclusion, pain and hunger: the impact of musculoskeletal impairments in the lives of children in Malawi. Disabil. Rehabil. 34: 1736-1746. Go to original source... Go to PubMed...
  3. Aleem M.A. 2005: Epilepsy in malaria. Epilepsia 46: 601; author reply 601-602. Go to original source... Go to PubMed...
  4. Amante F.H., Haque A., Stanley A.C., Rivera Fde L., Randall L.M., Wilson Y.A., Yeo G., Pieper C., Crabb B.S., de Koning-Ward T.F., Lundie R.J., Good M.F., Pinzon-Charry A., Pearson M.S., Duke M.G., McManus D.P., Loukas A., Hill G.R., Engwerda C.R. 2010: Immune-mediated mechanisms of parasite tissue sequestration during experimental cerebral malaria. J. Immunol. 185: 3632-3642. Go to original source... Go to PubMed...
  5. Ancelin M.L., Calas M., Vidal-Sailhan V., Herbute S., Ringwald P., Vial H.J. 2003: Potent inhibitors of Plasmodium phospholipid metabolism with a broad spectrum of in vitro antimalarial activities. Antimicrob. Agents Chemother. 47: 2590-2597. Go to original source... Go to PubMed...
  6. Apinjoh T.O., Ouattara A., Titanji V.P.K., Djimde A., Amambua-Ngwa A. 2019: Genetic diversity and drug resistance surveillance of Plasmodium falciparum for malaria elimination: is there an ideal tool for resource-limited sub-Saharan Africa? Malar. J. 18: 217. Go to original source... Go to PubMed...
  7. Apoorv T.S., Babu P.P. 2016: Minocycline prevents cerebral malaria, confers neuroprotection and increases survivability of mice during Plasmodium berghei ANKA infection. Cytokine 90: 113-123. Go to original source... Go to PubMed...
  8. Autino B., Corbett Y., Castelli F., Taramelli D. 2012: Pathogenesis of malaria in tissues and blood. Mediterr. J. Hematol. Infect. Dis. 4: e2012061. Go to original source... Go to PubMed...
  9. Azad C.S., Saxena M., Siddiqui A.J., Bhardwaj J., Puri S.K., Dutta G.P., Anand N., Saxena A.K. 2017: Synthesis of primaquine glyco-conjugates as potential tissue schizontocidal antimalarial agents. Chem. Biol. Drug. Des. 90: 254-261. Go to original source... Go to PubMed...
  10. Baird J.K., Masbar S., Basri H., Tirtokusumo S., Subianto B., Hoffman S.L. 1998: Age-dependent susceptibility to severe disease with primary exposure to Plasmodium falciparum. J. Infect. Dis. 178: 592-595. Go to original source... Go to PubMed...
  11. Bakmiwewa S.M., Weiser S., Grey M., Heng B., Guillemin G.J., Ball H.J., Hunt N.H. 2015: Synergistic induction of CXCL10 by interferon-gamma and lymphotoxin-alpha in astrocytes: possible role in cerebral malaria. Cytokine 78: 79-86. Go to original source... Go to PubMed...
  12. Baptista F.G., Pamplona A., Pena A.C., Mota M.M., Pied S., Vigario A.M. 2010: Accumulation of Plasmodium berghei-infected red blood cells in the brain is crucial for the development of cerebral malaria in mice. Infect. Immun. 78: 4033-4039. Go to original source... Go to PubMed...
  13. Baragana B., Hallyburton I., Lee M.C., Norcross N.R., Grimaldi R., Otto T.D., Proto W.R., Blagborough A.M., Meister S., Wirjanata G., Ruecker A., Upton L.M., Abraham T.S., Almeida M.J., Pradhan A., Porzelle A., Luksch T., Martinez M.S., Bolscher J.M., Woodland A., Norval S., Zuccotto F., Thomas J., Simeons F., Stojanovski L., Osuna-Cabello M., Brock P.M., Churcher T.S., Sala K.A., Zakutansky S.E., Jimenez-Diaz M.B., Sanz L.M., Riley J., Basak R., Campbell M., Avery V.M., Sauerwein R.W., Dechering K.J., Noviyanti R., Campo B., Frearson J.A., Angulo-Barturen I., Ferrer-Bazaga S., Gamo F.J., Wyatt P.G., Leroy D., Siegl P., Delves M.J., Kyle D.E., Wittlin S., Marfurt J., Price R.N., Sinden R.E., Winzeler E.A., Charman S.A., Bebrevska L., Gray D.W., Campbell S., Fairlamb A.H., Willis P.A., Rayner J.C., Fidock D.A., Read K.D., Gilbert I.H. 2015: A novel multiple-stage antimalarial agent that inhibits protein synthesis. Nature 522: 315-320. Go to original source... Go to PubMed...
  14. Beare N.A., Lewallen S., Taylor T.E., Molyneux M.E. 2011: Redefining cerebral malaria by including malaria retinopathy. Future Microbiol. 6: 349-355. Go to original source... Go to PubMed...
  15. Beare N.A., Southern C., Chalira C., Taylor T.E., Molyneux M.E., Harding S.P. 2004: Prognostic significance and course of retinopathy in children with severe malaria. Arch. Ophthalmol. 122: 1141-1147. Go to original source... Go to PubMed...
  16. Beare N.A., Taylor T.E., Harding S.P., Lewallen S., Molyneux M.E. 2006: Malarial retinopathy: a newly established diagnostic sign in severe malaria. Am. J. Trop. Med. Hyg. 75: 790-797. Go to original source... Go to PubMed...
  17. Bhardwaj J., Siddiqui A.J., Goyal M., Prakash K., Soni A., Puri S.K. 2016: Repetitive live sporozoites inoculation under arteether chemoprophylaxis confers protection against subsequent sporozoite challenge in rodent malaria model. Acta Trop. 158: 130-138. Go to original source... Go to PubMed...
  18. Bhardwaj J., Siddiqui A.J., Goyal M., Prakash K., Soni A., Puri S.K., Srivastava M. 2015: Host immune response is severely compromised during lethal Plasmodium vinckei infection. Parasitol. Res. 114: 3445-3457. Go to original source... Go to PubMed...
  19. Boivin M.J., Bangirana P., Byarugaba J., Opoka R.O., Idro R., Jurek A.M., John C.C. 2007: Cognitive impairment after cerebral malaria in children: a prospective study. Pediatrics 119: e360-366. Go to original source... Go to PubMed...
  20. Brejt J.A., Golightly L.M. 2019: Severe malaria: update on pathophysiology and treatment. Curr. Opin. Infect. Dis. 32: 413-418. Go to original source... Go to PubMed...
  21. Bruneel F. 2019: Human cerebral malaria: 2019 mini review. Rev. Neurol. (Paris) 175: 445-450. Go to original source... Go to PubMed...
  22. Burgess S.J., Kelly J.X., Shomloo S., Wittlin S., Brun R., Liebmann K., Peyton D.H. 2010: Synthesis, structure-activity relationship, and mode-of-action studies of antimalarial reversed chloroquine compounds. J. Med. Chem. 53: 6477-6489. Go to original source... Go to PubMed...
  23. Burkey M.D., Murray S.M., Bangirana P., Familiar I., Opoka R.O., Nakasujja N., Boivin M., Bass J.K. 2015: Executive function and attention-deficit/hyperactivity disorder in Ugandan children with perinatal HIV exposure. Glob. Ment. Health (Camb) 2: e4. Go to original source... Go to PubMed...
  24. Bushell E., Gomes A.R., Sanderson T., Anar B., Girling G., Herd C., Metcalf T., Modrzynska K., Schwach F., Martin R.E., Mather M.W., McFadden G.I., Parts L., Rutledge G.G., Vaidya A.B., Wengelnik K., Rayner J.C., Billker O. 2017: Functional profiling of a Plasmodium genome reveals an abundance of essential genes. Cell 170: 260-272 e268. Go to original source... Go to PubMed...
  25. Carter J.A., Lees J.A., Gona J.K., Murira G., Rimba K., Neville B.G., Newton C.R. 2006: Severe falciparum malaria and acquired childhood language disorder. Dev Med Child Neurol 48: 51-57. Go to original source... Go to PubMed...
  26. Carter J.A., Mung'ala-Odera V., Neville B.G., Murira G., Mturi N., Musumba C., Newton C.R. 2005a: Persistent neurocognitive impairments associated with severe falciparum malaria in Kenyan children. J. Neurol. Neurosurg. Psychiatry 76: 476-481. Go to original source... Go to PubMed...
  27. Carter J.A., Ross A.J., Neville B.G., Obiero E., Katana K., Mung'ala-Odera V., Lees J.A., Newton C.R. 2005b: Developmental impairments following severe falciparum malaria in children. Trop. Med. Int. Health 10: 3-10. Go to original source... Go to PubMed...
  28. Chakravorty S.J., Craig A. 2005: The role of ICAM-1 in Plasmodium falciparum cytoadherence. Eur. J. Cell. Biol. 84: 15-27. Go to original source... Go to PubMed...
  29. Chatterjee A.K., Yeung B.K. 2012: Back to the future: lessons learned in modern target-based and whole-cell lead optimization of antimalarials. Curr. Top. Med. Chem. 12: 473-483. Go to original source... Go to PubMed...
  30. Chitnis N., Pemberton-Ross P., Yukich J., Hamainza B., Miller J., Reiker T., Eisele T.P., Smith T.A. 2019: Theory of reactive interventions in the elimination and control of malaria. Malar. J. 18: 266. Go to original source... Go to PubMed...
  31. Claser C., Malleret B., Gun S.Y., Wong A.Y., Chang Z.W., Teo P., See P.C., Howland S.W., Ginhoux F., Renia L. 2011: CD8+ T cells and IFN-gamma mediate the time-dependent accumulation of infected red blood cells in deep organs during experimental cerebral malaria. PLoS ONE 6: e18720. Go to original source... Go to PubMed...
  32. Coteron J.M., Marco M., Esquivias J., Deng X., White K.L., White J., Koltun M., El Mazouni F., Kokkonda S., Katneni K., Bhamidipati R., Shackleford D.M., Angulo-Barturen I., Ferrer S.B., Jimenez-Diaz M.B., Gamo F.J., Goldsmith E.J., Charman W.N., Bathurst I., Floyd D., Matthews D., Burrows J.N., Rathod P.K., Charman S.A., Phillips M.A. 2011: Structure-guided lead optimization of triazolopyrimidine-ring substituents identifies potent Plasmodium falciparum dihydroorotate dehydrogenase inhibitors with clinical candidate potential. J. Med. Chem. 54: 5540-5561. Go to original source... Go to PubMed...
  33. Cowman A.F., Healer J., Marapana D., Marsh K. 2016: Malaria: biology and disease. Cell 167: 610-624. Go to original source... Go to PubMed...
  34. Crabb B.S., Beeson J.G., Amino R., Menard R., Waters A., Winzeler E.A., Wahlgren M., Fidock D.A., Nwaka S. 2012: Perspectives: the missing pieces. Nature 484: S22-23. Go to original source... Go to PubMed...
  35. Craig A., Scherf A. 2001: Molecules on the surface of the Plasmodium falciparum infected erythrocyte and their role in malaria pathogenesis and immune evasion. Mol. Biochem. Parasitol. 115: 129-143. Go to original source... Go to PubMed...
  36. Crawley J., Smith S., Kirkham F., Muthinji P., Waruiru C., Marsh K. 1996: Seizures and status epilepticus in childhood cerebral malaria. QJM 89: 591-597. Go to original source... Go to PubMed...
  37. Crompton P.D., Moebius J., Portugal S., Waisberg M., Hart G., Garver L.S., Miller L.H., Barillas-Mury C., Pierce S.K. 2014: Malaria immunity in man and mosquito: insights into unsolved mysteries of a deadly infectious disease. Annu. Rev. Immunol. 32: 157-187. Go to original source... Go to PubMed...
  38. Cunnington A.J., Walther M., Riley E.M. 2013: Piecing together the puzzle of severe malaria. Sci. Transl. Med. 5: 211ps218. Go to original source... Go to PubMed...
  39. Dai M., Freeman B., Shikani H.J., Bruno F.P., Collado J.E., Macias R., Reznik S.E., Davies P., Spray D.C., Tanowitz H.B., Weiss L.M., Desruisseaux M.S. 2012: Altered regulation of Akt signaling with murine cerebral malaria, effects on long-term neuro-cognitive function, restoration with lithium treatment. PLoS ONE 7: e44117. Go to original source... Go to PubMed...
  40. Daroff R.B. 2001: Cerebral malaria. J. Neurol. Neurosurg. Psychiatry 70: 817-818. Go to original source... Go to PubMed...
  41. Dayananda K.K., Achur R.N., Gowda D.C. 2018: Epidemiology, drug resistance, and pathophysiology of Plasmodium vivax malaria. J. Vector Borne Dis. 55: 1-8. Go to original source... Go to PubMed...
  42. de Miranda A.S., Brant F., Vieira L.B., Rocha N.P., Vieira E.L.M., Rezende G.H.S., de Oliveira Pimentel P.M., Moraes M.F.D., Ribeiro F.M., Ransohoff R.M., Teixeira M.M., Machado F.S., Rachid M.A., Teixeira A.L. 2016: A neuroprotective effect of the glutamate receptor antagonist MK801 on long-term cognitive and behavioral outcomes secondary to experimental cerebral malaria. Mol. Neurobiol. 54: 7063-7082. Go to original source... Go to PubMed...
  43. de Miranda A.S., Lacerda-Queiroz N., de Carvalho Vilela M., Rodrigues D.H., Rachid M.A., Quevedo J., Teixeira A.L. 2011: Anxiety-like behavior and proinflammatory cytokine levels in the brain of C57BL/6 mice infected with Plasmodium berghei (strain ANKA). Neurosci. Lett. 491: 202-206. Go to original source... Go to PubMed...
  44. Dechy-Cabaret O., Benoit-Vical F. 2012: Effects of antimalarial molecules on the gametocyte stage of Plasmodium falciparum: the debate. J. Med. Chem. 55: 10328-10344. Go to original source... Go to PubMed...
  45. DeWeerdt S. 2012: Vaccines: the take-home lesson. Nature 484: S24-25. Go to original source... Go to PubMed...
  46. Dollat M., Talla C., Sokhna C., Diene Sarr F., Trape J.F., Richard V. 2019: Measuring malaria morbidity in an area of seasonal transmission: pyrogenic parasitemia thresholds based on a 20-year follow-up study. PLoS ONE 14: e0217903. Go to original source... Go to PubMed...
  47. Dondorp A.M., Ince C., Charunwatthana P., Hanson J., van Kuijen A., Faiz M.A., Rahman M.R., Hasan M., Bin Yunus E., Ghose A., Ruangveerayut R., Limmathurotsakul D., Mathura K., White N.J., Day N.P. 2008b: Direct in vivo assessment of microcirculatory dysfunction in severe falciparum malaria. J. Infect. Dis. 197: 79-84. Go to original source... Go to PubMed...
  48. Dondorp A.M., Lee S.J., Faiz M.A., Mishra S., Price R., Tjitra E., Than M., Htut Y., Mohanty S., Yunus E.B., Rahman R., Nosten F., Anstey N.M., Day N.P., White N.J. 2008a: The relationship between age and the manifestations of and mortality associated with severe malaria. Clin. Infect. Dis. 47: 151-157. Go to original source... Go to PubMed...
  49. Dugbartey A.T., Dugbartey M.T., Apedo M.Y. 1998: Delayed neuropsychiatric effects of malaria in Ghana. J. Nerv. Ment. Dis. 186: 183-186. Go to original source... Go to PubMed...
  50. Eisenstein M. 2012: Drug development: holding out for reinforcements. Nature 484: S16-18. Go to original source... Go to PubMed...
  51. Engwerda C., Belnoue E., Gruner A.C., Renia L. 2005: Experimental models of cerebral malaria. Curr. Top. Microbiol. Immunol. 297: 103-143. Go to original source...
  52. Franke-Fayard B., Janse C.J., Cunha-Rodrigues M., Ramesar J., Buscher P., Que I., Lowik C., Voshol P.J., den Boer M.A., van Duinen S.G., Febbraio M., Mota M.M., Waters A.P. 2005: Murine malaria parasite sequestration: CD36 is the major receptor, but cerebral pathology is unlinked to sequestration. Proc. Natl. Acad. Sci. U.S.A. 102: 11468-11473. Go to original source... Go to PubMed...
  53. Frevert U., Nacer A. 2014: Fatal cerebral malaria: a venous efflux problem. Front. Cell. Infect. Microbiol. 4: 155. Go to original source... Go to PubMed...
  54. Ghazanfari N., Mueller S.N., Heath W.R. 2018: Cerebral malaria in mouse and man. Front. Immunol. 9: 2016. Go to original source... Go to PubMed...
  55. Hameed P.S., Solapure S., Patil V., Henrich P.P., Magistrado P.A., Bharath S., Murugan K., Viswanath P., Puttur J., Srivastava A., Bellale E., Panduga V., Shanbag G., Awasthy D., Landge S., Morayya S., Koushik K., Saralaya R., Raichurkar A., Rautela N., Roy Choudhury N., Ambady A., Nandishaiah R., Reddy J., Prabhakar K.R., Menasinakai S., Rudrapatna S., Chatterji M., Jimenez-Diaz M.B., Martinez M.S., Sanz L.M., Coburn-Flynn O., Fidock D.A., Lukens A.K., Wirth D.F., Bandodkar B., Mukherjee K., McLaughlin R.E., Waterson D., Rosenbrier-Ribeiro L., Hickling K., Balasubramanian V., Warner P., Hosagrahara V., Dudley A., Iyer P.S., Narayanan S., Kavanagh S., Sambandamurthy V.K. 2015: Triaminopyrimidine is a fast-killing and long-acting antimalarial clinical candidate. Nat. Commun. 6: 6715. Go to original source... Go to PubMed...
  56. Hawkes M., Elphinstone R.E., Conroy A.L., Kain K.C. 2013: Contrasting pediatric and adult cerebral malaria: the role of the endothelial barrier. Virulence 4: 543-555. Go to original source... Go to PubMed...
  57. Haynes R.K., Fugmann B., Stetter J., Rieckmann K., Heilmann H.D., Chan H.W., Cheung M.K., Lam W.L., Wong H.N., Croft S.L., Vivas L., Rattray L., Stewart L., Peters W., Robinson B.L., Edstein M.D., Kotecka B., Kyle D.E., Beckermann B., Gerisch M., Radtke M., Schmuck G., Steinke W., Wollborn U., Schmeer K., Romer A. 2006: Artemisone-a highly active antimalarial drug of the artemisinin class. Angew. Chem. Int. Ed. Engl. 45: 2082-2088. Go to original source... Go to PubMed...
  58. Hearn J., Rayment N., Landon D.N., Katz D.R., de Souza J.B. 2000: Immunopathology of cerebral malaria: morphological evidence of parasite sequestration in murine brain microvasculature. Infect. Immun. 68: 5364-5376. Go to original source... Go to PubMed...
  59. Heyes M.P., Saito K., Major E.O., Milstien S., Markey S.P., Vickers J.H. 1993: A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate. Brain 116: 1425-1450. Go to original source... Go to PubMed...
  60. Hien T.T., White N.J., Thuy-Nhien N.T., Hoa N.T., Thuan P.D., Tarning J., Nosten F., Magnusson B., Jain J.P., Hamed K. 2017: Estimation of the in vivo MIC of cipargamin in uncomplicated Plasmodium falciparum malaria. Antimicrob.Agents Chemother. 61: e01940-16. Go to original source... Go to PubMed...
  61. Holding P.A., Stevenson J., Peshu N., Marsh K. 1999: Cognitive sequelae of severe malaria with impaired consciousness. Trans. R. Soc. Trop. Med. Hyg. 93: 529-534. Go to original source... Go to PubMed...
  62. Hunt N.H., Grau G.E., Engwerda C., Barnum S.R., van der Heyde H., Hansen D.S., Schofield L., Golenser J. 2010: Murine cerebral malaria: the whole story. Trends Parasitol. 26: 272-274. Go to original source... Go to PubMed...
  63. Idro R., Carter J.A., Fegan G., Neville B.G., Newton C.R. 2006: Risk factors for persisting neurological and cognitive impairments following cerebral malaria. Arch. Dis. Child. 91: 142-148. Go to original source... Go to PubMed...
  64. Idro R., Jenkins N.E., Newton C.R. 2005: Pathogenesis, clinical features, and neurological outcome of cerebral malaria. Lancet Neurol. 4: 827-840. Go to original source... Go to PubMed...
  65. Idro R., Kakooza-Mwesige A., Asea B., Ssebyala K., Bangirana P., Opoka R.O., Lubowa S.K., Semrud-Clikeman M., John C.C., Nalugya J. 2016: Cerebral malaria is associated with long-term mental health disorders: a cross sectional survey of a long-term cohort. Malar. J. 15: 184. Go to original source... Go to PubMed...
  66. Idro R., Kakooza-Mwesige A., Balyejjussa S., Mirembe G., Mugasha C., Tugumisirize J., Byarugaba J. 2010a: Severe neurological sequelae and behaviour problems after cerebral malaria in Ugandan children. BMC Res. Notes. 3: 104. Go to original source... Go to PubMed...
  67. Idro R., Marsh K., John C.C., Newton C.R. 2010b: Cerebral malaria: mechanisms of brain injury and strategies for improved neurocognitive outcome. Pediatr. Res. 68: 267-274. Go to original source... Go to PubMed...
  68. John C.C., Bangirana P., Byarugaba J., Opoka R.O., Idro R., Jurek A.M., Wu B., Boivin M.J. 2008: Cerebral malaria in children is associated with long-term cognitive impairment. Pediatrics 122: e92-99. Go to original source... Go to PubMed...
  69. Jones C.O., Williams H.A. 2004: The social burden of malaria: what are we measuring? Am. J. Trop. Med. Hyg. 71: 156-161. Go to original source... Go to PubMed...
  70. Kerlin D.H., Gatton M.L. 2013: Preferential invasion by Plasmodium merozoites and the self-regulation of parasite burden. PLoS ONE 8: e57434. Go to original source... Go to PubMed...
  71. Kraemer S.M., Smith J.D. 2006: A family affair: var genes, PfEMP1 binding, and malaria disease. Curr. Opin. Microbiol. 9: 374-380. Go to original source... Go to PubMed...
  72. Lacerda-Queiroz N., Rodrigues D.H., Vilela M.C., Miranda A.S., Amaral D.C., Camargos E.R., Carvalho L.J., Howe C.L., Teixeira M.M., Teixeira A.L. 2010: Inflammatory changes in the central nervous system are associated with behavioral impairment in Plasmodium berghei (strain ANKA)-infected mice. Exp. Parasitol. 125: 271-278. Go to original source... Go to PubMed...
  73. Lackner P., Beer R., Heussler V., Goebel G., Rudzki D., Helbok R., Tannich E., Schmutzhard E. 2006: Behavioural and histopathological alterations in mice with cerebral malaria. Neuropathol. Appl. Neurobiol. 32: 177-188. Go to original source... Go to PubMed...
  74. Lewallen S., Bronzan R.N., Beare N.A., Harding S.P., Molyneux M.E., Taylor T.E. 2008: Using malarial retinopathy to improve the classification of children with cerebral malaria. Trans. R. Soc. Trop. Med. Hyg. 102: 1089-1094. Go to original source... Go to PubMed...
  75. Lou H.C., Henriksen L., Bruhn P., Borner H., Nielsen J.B. 1989: Striatal dysfunction in attention deficit and hyperkinetic disorder. Arch. Neurol. 46: 48-52. Go to original source... Go to PubMed...
  76. Luzolo A.L., Ngoyi D.M. 2019: Cerebral malaria. Brain Res. Bull. 145: 53-58 Go to original source... Go to PubMed...
  77. MacPherson G.G., Warrell M.J., White N.J., Looareesuwan S., Warrell D.A. 1985: Human cerebral malaria. A quantitative ultrastructural analysis of parasitized erythrocyte sequestration. Am. J. Pathol. 119: 385-401.
  78. Marcsisin S.R., Sousa J.C., Reichard G.A., Caridha D., Zeng Q., Roncal N., McNulty R., Careagabarja J., Sciotti R.J., Bennett J.W., Zottig V.E., Deye G., Li Q., Read L., Hickman M., Dhammika Nanayakkara N.P., Walker L.A., Smith B., Melendez V., Pybus B.S. 2014: Tafenoquine and NPC-1161B require CYP 2D metabolism for anti-malarial activity: implications for the 8-aminoquinoline class of anti-malarial compounds. Malar. J. 13: 2. Go to original source... Go to PubMed...
  79. Marsh K., Forster D., Waruiru C., Mwangi I., Winstanley M., Marsh V., Newton C., Winstanley P., Warn P., Peshu N., et al. 1995: Indicators of life-threatening malaria in African children. N Engl J Med 332: 1399-1404. Go to original source... Go to PubMed...
  80. Mbale E.W., Taylor T., Brabin B., Mallewa M., Gladstone M. 2017: Exploring neurodevelopmental outcome measures used in children with cerebral malaria: the perspectives of caregivers and health workers in Malawi. BMC Pediatr. 17: 9. Go to original source... Go to PubMed...
  81. Medana I.M., Day N.P., Hien T.T., White N.J., Turner G.D. 2009: Erythropoietin and its receptors in the brainstem of adults with fatal falciparum malaria. Malar. J. 8: 261. Go to original source... Go to PubMed...
  82. Meldrum B.S. 2000: Glutamate as a neurotransmitter in the brain: review of physiology and pathology. J. Nutr. 130: 1007S-1015S. Go to original source... Go to PubMed...
  83. Miranda A.S., Vieira L.B., Lacerda-Queiroz N., Souza A.H., Rodrigues D.H., Vilela M.C., Gomez M.V., Machado F.S., Rachid M.A., Teixeira A.L. 2010: Increased levels of glutamate in the central nervous system are associated with behavioral symptoms in experimental malaria. Braz. J. Med. Biol. Res. 43: 1173-1177. Go to original source... Go to PubMed...
  84. Moxon C.A., Wassmer S.C., Milner D.A., Jr., Chisala N.V., Taylor T.E., Seydel K.B., Molyneux M.E., Faragher B., Esmon C.T., Downey C., Toh C.H., Craig A.G., Heyderman R.S. 2013: Loss of endothelial protein C receptors links coagulation and inflammation to parasite sequestration in cerebral malaria in African children. Blood 122: 842-851. Go to original source... Go to PubMed...
  85. Nakamura T.A., Yamada K., Hasegawa T., Nabeshima T. 1995: Possible involvement of nitric oxide in quinolinic acid-induced convulsion in mice. Pharmacol. Biochem. Behav. 51: 309-312. Go to original source... Go to PubMed...
  86. Nelson F., Masulani-Mwale C., Richards E., Theobald S., Gladstone M. 2017: The meaning of participation for children in Malawi: insights from children and caregivers. Child Care Health Dev. 43: 133-143. Go to original source... Go to PubMed...
  87. Newbold C., Warn P., Black G., Berendt A., Craig A., Snow B., Msobo M., Peshu N., Marsh K. 1997: Receptor-specific adhesion and clinical disease in Plasmodium falciparum. Am. J. Trop. Med. Hyg. 57: 389-398. Go to original source... Go to PubMed...
  88. Newton C.R., Crawley J., Sowumni A., Waruiru C., Mwangi I., English M., Murphy S., Winstanley P.A., Marsh K., Kirkham F.J. 1997: Intracranial hypertension in Africans with cerebral malaria. Arch. Dis. Child 76: 219-226. Go to original source... Go to PubMed...
  89. Newton C.R., Krishna S. 1998: Severe falciparum malaria in children: current understanding of pathophysiology and supportive treatment. Pharmacol. Ther. 79: 1-53. Go to original source... Go to PubMed...
  90. Ngoungou E.B., Dulac O., Poudiougou B., Druet-Cabanac M., Dicko A., Mamadou Traore A., Coulibaly D., Farnarier G., Tuillas M., Keita M.M., Kombila M., Doumbo O.K., Preux P.M. 2006: Epilepsy as a consequence of cerebral malaria in area in which malaria is endemic in Mali, West Africa. Epilepsia 47: 873-879. Go to original source...
  91. Nguyen T.H., Day N.P., Ly V.C., Waller D., Mai N.T., Bethell D.B., Tran T.H., White N.J. 1996: Post-malaria neurological syndrome. Lancet 348: 917-921. Go to original source... Go to PubMed...
  92. Nishanth G., Schluter D. 2019: Blood-brain barrier in cerebral malaria: pathogenesis and therapeutic intervention. Trends Parasitol. 35: 516-528. Go to original source... Go to PubMed...
  93. Oliveira K., Kauffmann N., Leao L.K.R., Passos A.C.F., Rocha F.A.F., Herculano A.M., do Nascimento J.L.M. 2017: Cerebral malaria induces electrophysiological and neurochemical impairment in mice retinal tissue: possible effect on glutathione and glutamatergic system. Malar. J. 16: 440. Go to original source... Go to PubMed...
  94. Patel M., Sachidanandan M., Adnan M. 2019: Serine arginine protein kinase 1 (SRPK1): a moonlighting protein with theranostic ability in cancer prevention. Mol. Biol. Rep. 46: 1487-1497. Go to original source... Go to PubMed...
  95. Perkins D.J., Were T., Davenport G.C., Kempaiah P., Hittner J.B., Ong'echa J.M. 2011: Severe malarial anemia: innate immunity and pathogenesis. Int. J. Biol. Sci. 7: 1427-1442. Go to original source... Go to PubMed...
  96. Pongponratn E., Riganti M., Punpoowong B., Aikawa M. 1991: Microvascular sequestration of parasitized erythrocytes in human falciparum malaria: a pathological study. Am. J. Trop. Med. Hyg. 44: 168-175. Go to original source... Go to PubMed...
  97. Pongponratn E., Turner G.D., Day N.P., Phu N.H., Simpson J.A., Stepniewska K., Mai N.T., Viriyavejakul P., Looareesuwan S., Hien T.T., Ferguson D.J., White N.J. 2003: An ultrastructural study of the brain in fatal Plasmodium falciparum malaria. Am. J. Trop. Med. Hyg. 69: 345-359. Go to original source... Go to PubMed...
  98. Ponsford M.J., Medana I.M., Prapansilp P., Hien T.T., Lee S.J., Dondorp A.M., Esiri M.M., Day N.P., White N.J., Turner G.D. 2011: Sequestration and microvascular congestion are associated with coma in human cerebral malaria. J. Infect. Dis. 205: 663-671. Go to original source... Go to PubMed...
  99. Postels D.G., Birbeck G.L. 2013: Cerebral malaria. Handb. Clin. Neurol. 114: 91-102. Go to original source... Go to PubMed...
  100. Powles M.A., Allocco J., Yeung L., Nare B., Liberator P., Schmatz D. 2012: MK-4815, a potential new oral agent for treatment of malaria. Antimicrob. Agents Chemother. 56: 2414-2419. Go to original source... Go to PubMed...
  101. Prakash K., Goyal M., Soni A., Siddiqui A.J., Bhardwaj J., Puri S.K. 2014: Molecular cloning and biochemical characterization of iron superoxide dismutase from the rodent malaria parasite Plasmodium vinckei. Parasitol. Int. 63: 817-825. Go to original source... Go to PubMed...
  102. Prudencio M., Rodriguez A., Mota M.M. 2006: The silent path to thousands of merozoites: the Plasmodium liver stage. Nat. Rev. Microbiol. 4: 849-856. Go to original source... Go to PubMed...
  103. Reiner R.C., Jr., Olsen H.E., Ikeda C.T., Echko M.M., Ballestreros K.E., Manguerra H., Martopullo I., Millear A., Shields C., Smith A., Strub B., Abebe M., Abebe Z., Adhena B.M., Adhikari T.B., Akibu M., Al-Raddadi R.M., Alvis-Guzman N., Antonio C.A.T., Aremu O., Asgedom S.W., Asseffa N.A., Avila-Burgos L., Barac A., Barnighausen T.W., Bassat Q., Bensenor I.M., Bhutta Z.A., Bijani A., Bililign N., Cahuana-Hurtado L., Malta D.C., Chang J.C., Charlson F.J., Dharmaratne S.D., Doku D.T., Edessa D., El-Khatib Z., Erskine H.E., Ferrari A.J., Fullman N., Gupta R., Hassen H.Y., Hay S.I., Ilesanmi O.S., Jacobsen K.H., Kahsay A., Kasaeian A., Kassa T.D., Kebede S., Khader Y.S., Khan E.A., Khan M.N., Khang Y.H., Khubchandani J., Kinfu Y., Kochhar S., Kokubo Y., Koyanagi A., Defo B.K., Lal D.K., Kumsa F.A., Larson H.J., Leung J., Mamun A.A., Mehata S., Melku M., Mendoza W., Mezgebe H.B., Miller T.R., Moges N.A., Mohammed S., Mokdad A.H., Monasta L., Neupane S., Nguyen H.L.T., Ningrum D.N.A., Nirayo Y.L., Nong V.M., Ogbo F.A., Olagunju A.T., Olusanya B.O., Olusanya J.O., Patton G.C., Pereira D.M., Pourmalek F., Qorbani M., Rafay A., Rai R.K., Ram U., Ranabhat C.L., Renzaho A.M.N., Rezai M.S., Ronfani L., Roth G.A., Safiri S., Sartorius B., Scott J.G., Shackelford K.A., Sliwa K., Sreeramareddy C., Sufiyan M.B., Terkawi A.S., Topor-Madry R., Tran B.X., Ukwaja K.N., Uthman O.A., Vollset S.E., Weldegwergs K.G., Werdecker A., Whiteford H.A., Wijeratne T., Yonemoto N., Yotebieng M., Zuhlke L.J., Kyu H.H., Naghavi M., Vos T., Murray C.J.L., Kassebaum N.J. 2019: Diseases, injuries, and risk factors in child and adolescent health, 1990 to 2017: findings from the global burden of diseases, injuries, and risk factors 2017 study. JAMA Pediatr. 173: e190337. Go to original source... Go to PubMed...
  104. Riggle B.A., Miller L.H., Pierce S.K. 2020: Desperately seeking therapies for cerebral malaria. J. Immunol. 204: 327-334. Go to original source... Go to PubMed...
  105. Roggero R., Zufferey R., Minca M., Richier E., Calas M., Vial H., Ben Mamoun C. 2004: Unraveling the mode of action of the antimalarial choline analog G25 in Plasmodium falciparum and Saccharomyces cerevisiae. Antimicrob. Agents Chemother. 48: 2816-2824. Go to original source... Go to PubMed...
  106. Sahu P.K., Satpathi S., Behera P.K., Mishra S.K., Mohanty S., Wassmer S.C. 2015: Pathogenesis of cerebral malaria: new diagnostic tools, biomarkers, and therapeutic approaches. Front. Cell. Infect. Microbiol. 5: 75. Go to original source... Go to PubMed...
  107. Samby K., Ramachandruni H., Banerji J., Burrows J.N., Daumerie P.G., Hooft van Huijsduijnen R.A.M., Duparc S., Wells T.N.C. 2019: Partnering to fight malaria in India: past, present and future. J. Vector Borne Dis. 56: 15-24. Go to original source... Go to PubMed...
  108. Schantz-Dunn J., Nour N.M. 2009: Malaria and pregnancy: a global health perspective. Rev. Obstet. Gynecol. 2: 186-192.
  109. Schumacher R.F., Spinelli E. 2012: Malaria in children. Mediterr. J. Hematol. Infect. Dis. 4: e2012073. Go to original source... Go to PubMed...
  110. Scott J.A., Berkley J.A., Mwangi I., Ochola L., Uyoga S., Macharia A., Ndila C., Lowe B.S., Mwarumba S., Bauni E., Marsh K., Williams T.N. 2011: Relation between falciparum malaria and bacteraemia in Kenyan children: a population-based, case-control study and a longitudinal study. Lancet 378: 1316-1323. Go to original source... Go to PubMed...
  111. Shafiq N., Rajagopalan S., Kushwaha H.N., Mittal N., Chandurkar N., Bhalla A., Kaur S., Pandhi P., Puri G.D., Achuthan S., Pareek A., Singh S.K., Srivastava J.S., Gaur S.P., Malhotra S. 2014: Single ascending dose safety and pharmacokinetics of CDRI-97/78: first-in-human study of a novel antimalarial drug. Malar. Res. Treat. 2014: 372521. Go to original source... Go to PubMed...
  112. Shetty P. 2012: The numbers game. Nature 484: S14-15. Go to original source... Go to PubMed...
  113. Shikani H.J., Freeman B.D., Lisanti M.P., Weiss L.M., Tanowitz H.B., Desruisseaux M.S. 2012: Cerebral malaria: we have come a long way. Am. J. Pathol. 181: 1484-1492. Go to original source... Go to PubMed...
  114. Siddiqui A.J., Bhardwaj J., Goyal M., Prakash K., Soni A., Tiwari V., Puri S.K. 2015: Assessment of real-time method to detect liver parasite burden under different experimental conditions in mice infected with Plasmodium yoelii sporozoites. Microb. Pathog. 89: 35-42. Go to original source... Go to PubMed...
  115. Siddiqui A.J., Bhardwaj J., Puri S.K. 2011: mRNA expression of cytokines and its impact on outcomes after infection with lethal and nonlethal Plasmodium vinckei parasites. Parasitol. Res. 110: 1517-1524. Go to original source... Go to PubMed...
  116. Siddiqui A.J., Molehin A.J., Zhang W., Ganapathy P.K., Kim E., Rojo J.U., Redman W.K., Sennoune S.R., Sudduth J., Freeborn J., Hunter D., Kottapalli K.R., Kottapalli P., Wettashinghe R., van Dam G.J., Corstjens P., Papin J.F., Carey D., Torben W., Ahmad G., Siddiqui A.A. 2018: Sm-p80-based vaccine trial in baboons: efficacy when mimicking natural conditions of chronic disease, praziquantel therapy, immunization, and Schistosoma mansoni re-encounter. Ann. N. Y. Acad. Sci. 1425: 19-37. Go to original source... Go to PubMed...
  117. Silamut K., Phu N.H., Whitty C., Turner G.D., Louwrier K., Mai N.T., Simpson J.A., Hien T.T., White N.J. 1999:A quantitative analysis of the microvascular sequestration of malaria parasites in the human brain. Am. J. Pathol. 155: 395-410. Go to original source... Go to PubMed...
  118. Singh A., Yeh C.J., Verma N., Das A.K. 2016: Overview of attention deficit hyperactivity disorder in young children. Health Psychol. Res. 3: 2115. Go to original source... Go to PubMed...
  119. Sokol D.K., Demyer W.E., Edwards-Brown M., Sanders S., Garg B. 2003: From swelling to sclerosis: acute change in mesial hippocampus after prolonged febrile seizure. Seizure 12: 237-240. Go to original source... Go to PubMed...
  120. Soni A., Goyal M., Prakash K., Bhardwaj J., Siddiqui A.J., Puri S.K. 2015: Cloning, expression and functional characterization of heme detoxification protein (HDP) from the rodent malaria parasite Plasmodium vinckei. Gene 566: 109-119. Go to original source... Go to PubMed...
  121. Ssentongo P., Robuccio A.E., Thuku G., Sim D.G., Nabi A., Bahari F., Shanmugasundaram B., Billard M.W., Geronimo A., Short K.W., Drew P.J., Baccon J., Weinstein S.L., Gilliam F.G., Stoute J.A., Chinchilli V.M., Read A.F., Gluckman B.J., Schiff S.J. 2017: A murine model to study epilepsy and SUDEP induced by malaria infection. Sci. Rep. 7: 43652. Go to original source... Go to PubMed...
  122. Stone T.W., Connick J.H., Winn P., Hastings M.H., English M. 1987: Endogenous excitotoxic agents. Ciba Found. Symp. 126: 204-220. Go to original source... Go to PubMed...
  123. Strangward P., Haley M.J., Shaw T.N., Schwartz J.M., Greig R., Mironov A., de Souza J.B., Cruickshank S.M., Craig A.G., Milner D.A., Jr., Allan S.M., Couper K.N. 2017: A quantitative brain map of experimental cerebral malaria pathology. PLoS Pathog. 13: e1006267. Go to original source... Go to PubMed...
  124. Stresman G., Bousema T., Cook J. 2019: Malaria hotspots: is there epidemiological evidence for fine-scale spatial targeting of interventions? Trends. Parasitol. 35: 822-834. Go to original source... Go to PubMed...
  125. Taylor T.E., Fu W.J., Carr R.A., Whitten R.O., Mueller J.S., Fosiko N.G., Lewallen S., Liomba N.G., Molyneux M.E. 2004: Differentiating the pathologies of cerebral malaria by postmortem parasite counts. Nat. Med. 10: 143-145. Go to original source... Go to PubMed...
  126. Thievent K., Zilio G., Hauser G., Koella J.C. 2019: Malaria load affects the activity of mosquito salivary apyrase. J. Insect. Physiol. 116: 10-16. Go to original source... Go to PubMed...
  127. Tse E.G., Korsik M., Todd M.H. 2019: The past, present and future of anti-malarial medicines. Malar. J. 18: 93. Go to original source... Go to PubMed...
  128. Turner L., Lavstsen T., Berger S.S., Wang C.W., Petersen J.E., Avril M., Brazier A.J., Freeth J., Jespersen J.S., Nielsen M.A., Magistrado P., Lusingu J., Smith J.D., Higgins M.K., Theander T.G. 2013: Severe malaria is associated with parasite binding to endothelial protein C receptor. Nature 498: 502-505. Go to original source... Go to PubMed...
  129. Vennerstrom J.L., Arbe-Barnes S., Brun R., Charman S.A., Chiu F.C., Chollet J., Dong Y., Dorn A., Hunziker D., Matile H., McIntosh K., Padmanilayam M., Santo Tomas J., Scheurer C., Scorneaux B., Tang Y., Urwyler H., Wittlin S., Charman W.N. 2004: Identification of an antimalarial synthetic trioxolane drug development candidate. Nature 430: 900-904. Go to original source... Go to PubMed...
  130. Walker O., Salako L.A., Sowunmi A., Thomas J.O., Sodeine O., Bondi F.S. 1992: Prognostic risk factors and post mortem findings in cerebral malaria in children. Trans. R. Soc. Trop. Med. Hyg. 86: 491-493. Go to original source... Go to PubMed...
  131. Wassmer S.C., Taylor T.E., Rathod P.K., Mishra S.K., Mohanty S., Arevalo-Herrera M., Duraisingh M.T., Smith J.D. 2015: Investigating the Pathogenesis of Severe Malaria: A Multidisciplinary and Cross-Geographical Approach. Am. J. Trop. Med. Hyg. 93: 42-56. Go to original source... Go to PubMed...
  132. Wells T.N., Hooft van Huijsduijnen R., Van Voorhis W.C. 2015: Malaria medicines: a glass half full? Nat. Rev. Drug. Discov. 14: 424-442. Go to original source... Go to PubMed...
  133. White N.J., Pukrittayakamee S., Hien T.T., Faiz M.A., Mokuolu O.A., Dondorp A.M. 2013: Malaria. Lancet 383: 723-735. Go to original source...
  134. WHO 2006: World Malaria Report 2006. World Health Organisation, Geneva.
  135. WHO 2011: World Malaria Report 2011. World Health Organisation, Geneva.
  136. WHO 2015: World Malaria Report 2015. World Health Organisation, Geneva.
  137. WHO 2017: World Malaria Report 2017. World Health Organisation, Geneva.
  138. WHO 2018: World Malaria Report 2018. World Health Organisation, Geneva.
  139. Wijdicks E.F.M., Park J.G. 2018: Surviving cerebral malaria. Neurology 91: 978-979. Go to original source... Go to PubMed...
  140. Wilson K.D., Stutz S.J., Ochoa L.F., Valbuena G.A., Cravens P.D., Dineley K.T., Vargas G., Stephens R. 2016: Behavioural and neurological symptoms accompanied by cellular neuroinflammation in IL-10-deficient mice infected with Plasmodium chabaudi. Malar. J. 15: 428. Go to original source... Go to PubMed...
  141. Win Han O., Gold L., Moore K., Agius P.A., Fowkes F.J.I. 2019: The impact of community-delivered models of malaria control and elimination: a systematic review. Malar. J. 18: 269. Go to original source... Go to PubMed...
  142. Yadav D.K., Kumar S., Teli M.K., Yadav R., Chaudhary S. 2019: Molecular targets for malarial chemotherapy: a review. Curr. Top. Med. Chem. 19: 861-873. Go to original source... Go to PubMed...
  143. Yuthavong Y., Tarnchompoo B., Vilaivan T., Chitnumsub P., Kamchonwongpaisan S., Charman S.A., McLennan D.N., White K.L., Vivas L., Bongard E., Thongphanchang C., Taweechai S., Vanichtanankul J., Rattanajak R., Arwon U., Fantauzzi P., Yuvaniyama J., Charman W.N., Matthews D. 2012: Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised target. Proc. Natl. Acad. Sci. U. S. A. 109: 16823-16828. Go to original source... Go to PubMed...
  144. Zhang W., Ahmad G., Molehin A.J., Torben W., Le L., Kim E., Lazarus S., Siddiqui A.J., Carter D., Siddiqui A.A. 2018a: Schistosoma mansoni antigen Sm-p80: prophylactic efficacy using TLR4 agonist vaccine adjuvant glucopyranosyl lipid A-Alum in murine and non-human primate models. J. Investig. Med. 66: 1124-1132. Go to original source... Go to PubMed...
  145. Zhang W., Molehin A.J., Rojo J.U., Sudduth J., Ganapathy P.K., Kim E., Siddiqui A.J., Freeborn J., Sennoune S.R., May J., Lazarus S., Nguyen C., Redman W.K., Ahmad G., Torben W., Karmakar S., Le L., Kottapalli K.R., Kottapalli P., Wolf R.F., Papin J.F., Carey D., Gray S.A., Bergthold J.D., Damian R.T., Mayer B.T., Marks F., Reed S.G., Carter D., Siddiqui A.A. 2018b: Sm-p80-based schistosomiasis vaccine: double-blind preclinical trial in baboons demonstrates comprehensive prophylactic and parasite transmission-blocking efficacy. Ann. N. Y. Acad. Sci. 1425: 38-51. Go to original source... Go to PubMed...